Tumor Marker Blood Test Doctors Abroad — Page 6

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.

Dr. Ali Ihsan Anadolulu is a surgical specialist at Central Hospital in Istanbul. He focuses on pediatric gastrointestinal surgery and anorectal malformations. Dr. Anadolulu treats complex colorectal and pelvic floor disorders in children. He uses minimally invasive techniques for pediatric surgical cases.

• Performs specialized surgeries for nephroblastoma and rhabdomyosarcoma removal.
• Treats motility disorders and anorectal malformations in pediatric patients.
• Expert in pituitary tumor surgery for children and adolescents.
• Works at Central Hospital, which features modern neonatal intensive care units.

Dr. Seymur Aslanov is a gastroenterologist at Medicalpoint International Hospital in İzmir. He completed his subspecialty training at Ege University. Dr. Aslanov treats inflammatory bowel diseases, liver disorders, and digestive system cancers. He is a member of the Izmir Medical Chamber.

• Performs ERCP and endoscopic procedures to treat biliary tract diseases.
• Treats Crohn's disease and ulcerative colitis using stem cell therapy.
• Surgical expertise includes endoscopic polypectomy and stenting for gastrointestinal stenosis.
• Works at a JCI-accredited hospital with ISO and TEMOS quality certifications.

Dr. Omer Burcak Binicier is a gastroenterologist at Medicalpoint International Hospital in Izmir. He focuses on early-stage gastrointestinal cancers and inflammatory bowel diseases. Dr. Binicier completed international training at the Korea University Faculty of Medicine. He treats complex liver, pancreatic, and digestive system disorders using manual and robotic-assisted techniques.

• Performs therapeutic endoscopy including EMR, ESD, and ERCP.
• Provides minimally invasive obesity treatments like intragastric balloons.
• Expert in endoscopic ultrasound for precise digestive tract imaging.
• Practices at JCI-accredited Medicalpoint International Hospital.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at Liv Hospital Topkapı. He specializes in treating colon, breast, gastric, and lung cancers. He previously served as the Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital. Dr. Atci is a member of the American Society of Clinical Oncology (ASCO).

• Author of 19 peer-reviewed papers on gastrointestinal, thoracic, and endocrine cancers.
• Published studies on survival outcomes for stage IIB colon cancer in the Journal of Chemotherapy.
• Researches prognostic biomarkers using PET/CT scans and metabolic tumor volume.
• Treats complex oncological cases at the university-affiliated İstinye University clinic.

Dr. Yu Yeonghun is a gastrointestinal surgeon with a Ph.D. in Medicine. He specializes in hepato-pancreato-biliary (HPB) diseases and cancers. His focus includes liver, pancreas, biliary tract, and gallbladder cancers, as well as cholelithiasis and other gallbladder diseases.

He completed his internship and general surgery residency at CHA Bundang Medical Center. He then finished an HPB surgery fellowship at Samsung Medical Center. He has served as Clinical Assistant Professor of Surgery at Konkuk University Choongju Hospital and at Samsung Medical Center. He later became Professor of Surgery at Eulji University Hospital.

He is a Lifetime Member of The Korean Surgical Society and the Korean Association of Hepato-Biliary-Pancreatic Surgery (KAHBPS). He serves on the KAHBPS Planning Committee and Tumor Registry Committee.

Dr. Nurten Dinckal is an internal medicine specialist at Neolife Medical Center (2025–present). She earned her MD (English Program) from Marmara University Faculty of Medicine (1986–1993). She completed a general surgery residency at Marmara University. She later trained in internal medicine at Haydarpasa Numune Hospital and Celal Bayar University.

Her prior posts include specialist in internal medicine at Izmir Ataturk Training Hospital (2000–2001) and Gaziantep State Hospital (2002–2007). She also held staff roles at International Hospital Levent Medical Center (2008–2009) and Bayindir Levent Surgical Medical Center (2009–2025).

She is a member of the Turkish Society of Internal Medicine and the Chamber of Physicians. Her clinical interests include diabetes, anemia, metabolic syndrome, lung infections, fatty liver disease, and hyperlipidemia.

Professor Park Jung-won is a leading Korean specialist in hepatocellular carcinoma with over 30 years of experience. He is the Director of the Liver and Liver Cancer Center and the Integrated Cancer Care Center at Myongji Hospital. He led Korea’s first HCC guidelines in 2003. He has also overseen their updates for about 20 years. His team validated proton beam radiotherapy for liver cancer, as published in the Journal of Hepatology. He has authored more than 200 SCI-indexed papers. He also helped lead global trials, including the 2025 CheckMate 9DW study, which showed improved outcomes with nivolumab plus ipilimumab for unresectable HCC.

MD/PhD, Seoul National University; Member, National Academy of Medicine of Korea; former President, Korean Liver Cancer Association; Chair, Korean HCC Guidelines Committee; Prime Minister’s and Health Minister’s commendations; Pfizer Medical Research Award and Roche Oncology Academic Award.

Dr. Song Hwayeong is a gastroenterologist. Areas of focus include gastrointestinal cancers (stomach and esophageal) and advanced endoscopy (gastroscopy, colonoscopy, ESD, and polypectomy). Dr. Song also treats digestive and liver diseases, including GERD, gastritis, hepatitis, H. pylori infection, and liver disease.

Dr. Song completed a fellowship in Gastroenterology at Inje University Ilsan Paik Hospital. Dr. Song has served as Clinical Professor at Inje, Gachon, and Inha University Colleges of Medicine. Dr. Song is Director of the Gastroenterology Center at Naeun Hospital.

Accreditations: full member of the Korean Association of Internal Medicine, the Korean Society of Gastrointestinal Endoscopy, and the Korean Gastroenterology Association. Doping Committee Member, WKBL.

Selected papers: cryptogenic hepatocellular carcinoma; primary biliary cirrhosis with overlap syndromes; therapy for lamivudine-resistant chronic hepatitis B; and clevudine in HBV-related cirrhosis.